GeNeuro SA (GNRO.PA)

EUR 0.08

(6.38%)

Inventory Summary of GeNeuro SA

  • GeNeuro SA's latest annual inventory in 2023 was - EUR , down 0.0% from previous year.
  • GeNeuro SA's latest quarterly inventory in 2023 FY was - EUR , down 0.0% from previous quarter.
  • GeNeuro SA reported annual inventory of - EUR in 2022, down 0.0% from previous year.
  • GeNeuro SA reported annual inventory of - EUR in 2021, down 0.0% from previous year.
  • GeNeuro SA reported quarterly inventory of - EUR for 2023 Q4, down 0.0% from previous quarter.
  • GeNeuro SA reported quarterly inventory of - EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Inventory Chart of GeNeuro SA (2023 - 2013)

Historical Annual Inventory of GeNeuro SA (2023 - 2013)

Year Inventory Inventory Growth
2023 - EUR 0.0%
2022 - EUR 0.0%
2021 - EUR 0.0%
2020 - EUR 0.0%
2019 - EUR 100.0%
2018 -2.86 Million EUR -107.4%
2017 -1.38 Million EUR -103.3%
2016 -679.7 Thousand EUR 9.36%
2015 -749.9 Thousand EUR 0.0%
2014 - EUR 0.0%
2013 - EUR 0.0%

Peer Inventory Comparison of GeNeuro SA

Name Inventory Inventory Difference
ABIONYX Pharma SA 221 Thousand EUR 100.0%
ABIVAX Société Anonyme 1.00 EUR 100.0%
Adocia SA 272 Thousand EUR 100.0%
Aelis Farma SA 53 Thousand EUR 100.0%
Biophytis S.A. - EUR NaN%
Advicenne S.A. 1.74 Million EUR 100.0%
genOway Société anonyme 982.75 Thousand EUR 100.0%
IntegraGen SA 311.44 Thousand EUR 100.0%
Medesis Pharma S.A. 164.62 Thousand EUR 100.0%
Neovacs S.A. - EUR NaN%
NFL Biosciences SA -1.1 Million EUR 100.0%
Plant Advanced Technologies SA 1.22 Million EUR 100.0%
Quantum Genomics Société Anonyme -119.17 Thousand EUR 100.0%
Sensorion SA - EUR NaN%
Theranexus Société Anonyme - EUR NaN%
TME Pharma N.V. 91 Thousand EUR 100.0%
Valbiotis SA 1 Million EUR 100.0%
TheraVet SA 123.34 Thousand EUR 100.0%
Valerio Therapeutics Société anonyme 1.00 EUR 100.0%
argenx SE 281.12 Million EUR 100.0%
BioSenic S.A. - EUR NaN%
Celyad Oncology SA 1.26 Million EUR 100.0%
DBV Technologies S.A. 1.00 USD 100.0%
Galapagos NV 73.97 Million EUR 100.0%
Genfit S.A. 4000.00 EUR 100.0%
Hyloris Pharmaceuticals SA 1.00 EUR 100.0%
Innate Pharma S.A. 1.00 EUR 100.0%
Inventiva S.A. 417 Thousand EUR 100.0%
MaaT Pharma SA 190 Thousand EUR 100.0%
MedinCell S.A. -6.71 Million EUR 100.0%
Nanobiotix S.A. 200 Thousand EUR 100.0%
Onward Medical N.V. 936 Thousand EUR 100.0%
Oryzon Genomics S.A. 6029.00 EUR 100.0%
OSE Immunotherapeutics SA - EUR NaN%
Oxurion NV 128 Thousand EUR 100.0%
Pharming Group N.V. 51.38 Million EUR 100.0%
Poxel S.A. 2.95 Million EUR 100.0%
GenSight Biologics S.A. 1.00 EUR 100.0%
Transgene SA - EUR NaN%
Financière de Tubize SA - EUR NaN%
UCB SA 1.03 Billion EUR 100.0%
Valneva SE 44.46 Million EUR 100.0%
Vivoryon Therapeutics N.V. 1.00 EUR 100.0%